High court seems likely to side with Merck in Fosamax case

The Supreme Court seems likely to side with drugmaker Merck in a dispute over the warning label on its bone-strengthening drug Fosamax

from ABC News: Health https://abcn.ws/2CW8fYF
via HEALTH